Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics

Schizophrenia was first described by Emil Krapelin in the 19th century as one of the major mental illnesses causing disability worldwide. Since the introduction of chlorpromazine in 1952, strategies aimed at modifying the activity of dopamine receptors have played a major role for the treatment of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasciani, Irene, Petragnano, Francesco, Aloisi, Gabriella, Marampon, Francesco, Carli, Marco, Scarselli, Marco, Maggio, Roberto, Rossi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696972/
https://www.ncbi.nlm.nih.gov/pubmed/33202534
http://dx.doi.org/10.3390/ph13110388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696972/
https://www.ncbi.nlm.nih.gov/pubmed/33202534
http://dx.doi.org/10.3390/ph13110388

Ejemplares similares